Drug search by name

Allopurinol Intravenous and Bone marrow suppression

Result of checking the interaction of drug Allopurinol Intravenous and disease Bone marrow suppression for safety when used together.

Check result:

Allopurinol Intravenous <> Bone marrow suppression

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Bone marrow suppression has been reported in patients receiving allopurinol; however, most of these patients were receiving concomitant medications with the known potential to cause such an effect. The suppression has occurred from as early as 6 weeks to as long as 6 years after the initiation of allopurinol therapy. Therapy with allopurinol should be administered cautiously to patients with or predisposed to bone marrow suppression.

Allopurinol Intravenous

Generic Name: allopurinol

Brand Name: Zyloprim, Lopurin, Aloprim

Synonyms: Allopurinol

What is Allopurinol Intravenous?